Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 50

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 50
---
DAQ under the symbol “HURA.”

19

DESCRIPTION OF WARRANTS We may issue warrants in the future for the purchase of debt securities, common stock or other securities. Warrants may be issued independently or together with debt securities or common stock offered by any prospectus supplement and/or other offering material and may be attached to or separate from any such offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and the warrant holder, with the option to also utilize a bank or trust company, as warrant agent, all as will be set forth in the prospectus supplement and/or other offering material relating to the particular issue of warrants. The warrant agent, if any, will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders of warrants or beneficial owners of warrants. The following summary of certain provisions of the warrants we may issue in the future does not purport to be complete and is subject to, and is qualified in its entirety by reference to, all provisions of the warrant agreements. Reference is made to the prospectus supplement and/or other offering material relating to the particular issue of warrants offered pursuant to such prospectus supplement and/or other offering material for the terms of and information relating to such warrants, including, where applicable:

| • |     | the designation, aggregate principal amount, currencies, denominations and terms of the series of debt securities                                  
 purchasable upon exercise of warrants to purchase debt securities and the price at which such debt securities may be purchased upon such exercise; |

| • |     | the number of shares of common stock purchasable upon the exercise of warrants to purchase common stock and the 
 price at which such number of shares of common stock may be purchased upon such exercise;                       |

| • |     | the designation and number of units of other securities purchasable upon the exercise of warrants to purchase              
 other securities and the price at which such number of units of such other securities may be purchased upon such exercise; |

| • |     | the date on which the right to exercise such warrants shall commence and the date on which such right shall 
 expire;                                                                                                     |

| • |     | U.S. federal income tax consequences applicable to such warrants; |

| • |     | the amount of warrants outstanding as of the most recent practicable date; and |

| • |     | any other terms of such warrants. |

The exercise price for warrants will be subject to adjustment in accordance